Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Dighe, Niraja ^a   Khoury, Maroun ^b   Mattar, Citra ^a   Chong, Mark ^a,c   Choolani, Mahesh ^a   Chen, Jianzhu ^b,d   Antoniou, Michael N ^e   Chan, Jerry K Y ^a,f,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c Nanyang Technological University   (Singapore)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e GUY S HOSPITAL   (United Kingdom)

^f KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1ALPHA; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HNRNP A2;

ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; CONTROLLED STUDY; FETUS; FETUS LIVER; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HNRPA2B1 CBX3 GENE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; STEM CELL CULTURE; TRANSGENE; UBIQUITOUS CHROMATIN OPENING ELEMENT; UMBILICAL CORD BLOOD; ANIMAL; CYTOLOGY; DNA METHYLATION; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETICS; LENTIVIRINAE; LIVER; METABOLISM; MOLECULARLY TARGETED THERAPY; NONOBESE DIABETIC MOUSE; PROCEDURES; SCID MOUSE;

ANIMALS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LENTIVIRUS; LIVER; MICE; MICE, INBRED NOD; MICE, SCID; MOLECULAR TARGETED THERAPY; PHOSPHOGLYCERATE KINASE; PROMOTER REGIONS, GENETIC; TRANSGENES;

EID: 84905841305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104805     Document Type: Article

References (47)

1. Frecha C, Costa C, Nègre D, Amirache F, Trono D, et al. (2012) A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice. Blood 119: 1139-1150.
2. Cavazzana-Calvo M, André-Schmutz I, Fischer A (2013) Haematopoietic stem cell transplantation for SCID patients: where do we stand? Br J Haematol 160: 146-152.
3. Cavazzana-Calvo M, Fischer A, Hacein-Bey-Abina S, Aiuti A (2012) Gene therapy for primary immunodeficiencies: Part 1. Curr Opin Immunol 24: 580-584.
4. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672. (Pubitemid 30241569)
5. Aiuti A, Brigida I, Ferrua F, Cappelli B, Chiesa R, et al. (2009) Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID. Immunol Res 44: 150-159.
6. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, et al. (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
7. Gluckman E (2009) Ten years of cord blood transplantation: from bench to bedside. British Journal of haematology 147: 192-199.
8. Wu MH, Smith SL, Dolan ME (2001) High Efficiency Electroporation of Human Umbilical Cord Blood CD34+ Hematopoietic Precursor Cells. Stem Cells 19: 492-499. (Pubitemid 33095844)
9. Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, et al. (2003) Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. Gene Ther 10: 272-277. (Pubitemid 36204416)
10. Papapetrou EP, Zoumbos NC, Athanassiadou A (2005) Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects. Gene Ther 12: S118-S130. (Pubitemid 41541761)
11. Chan J, O'Donoghue K, de la Fuente J, Roberts IA, Kumar S, et al. (2005) Human Fetal Mesenchymal Stem Cells as Vehicles for Gene Delivery. Stem Cells 23: 93-102. (Pubitemid 40105295)
12. Miyoshi H, Smith K, Mosier D, Verma I, Torbett B (1999) Transduction of Human CD34+ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors. Science 283: 682-686.
13. Piacibello W, Bruno S, Sapavo F, Droetto S, Gunetti M, et al. (2002) Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Blood 100: 4391-4400. (Pubitemid 35429677)
14. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, et al. (1998) Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery. Journal of Virology 72: 9873-9880. (Pubitemid 28520853)
15. Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, et al. (2004) Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187. (Pubitemid 40018447)
16. Antoniou MN, Skipper KA, Anakok O (2013) Optimizing retroviral gene expression for effective therapies. Human Gene Therapy 24 363-374.
17. Ellis J (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Human Gene Ther 16: 1241-1246.
18. Nielsen TT, Jakobsson J, Rosenqvist N, Lundberg C (2009) Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants. BMC Biotehnol 9.
19. Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, et al. (2009) Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther 17: 1527-1536.
20. Zhang F, Thornhill S, Howe SJ, Ulaganathan M, Schambach A, et al. (2007) Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 110: 1448-1457. (Pubitemid 47443959)
21. Zhang F, Frost AR, Blundell MP, Bales O, Antoniou MN, et al. (2010) A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation-mediated Silencing of Lentiviral Vectors. Molecular Therapy 18: 1640-1649.
22. Ackermann M, Lachmann N, Hartung S, Eggenschwiler R, Pfaff N, et al. (2014) Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials 35: 1531-1542.
23. Pfaff N, Lachmann N, Ackermann M, Kohlscheen S, Brendel C, et al. (2013) A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31: 488-499.
24. Case SS, Price MA, Jordon CT, Yu XJ, Wang L, et al. (1999) Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A 96: 2988-2993. (Pubitemid 29148831)
25. Khoury M, Drake AC, Chen Q, Dong D, Leskov I, et al. (2011) Mesenchymal Stem Cells Secreting Angiopoietin-Like-5 Support Efficient Expansion of Human Hematopoietic Stem Cells Without Compromising Their Repopulating Potential. Stem Cells and Development 20: 1371-1381.
26. Drake AC, Khoury M, Leskov I, Iliopoulou BP, Fragoso M, et al. (2011) Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ/- (NSG) mice. Plos One 6 (4): 1-9.
27. Naldini L (2011) Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 12: 301-315.
28. Stein S, Scholz S, Schwäble J, Sadat MA, Modlich U, et al. (2013) From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease. Hum Gene Ther Clin Dev 24: 86-98
29. Tolar J, Becker PS, Clapp DW, Hanenberg H, de Heredia CD, et al. (2012) Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther 23: 141-144.
30. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, et al. (2010) Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia. Nature 467: 318-322.
31. Brendel C, Muller-Kuller U, Schultze-Strasser S, Stein S, Chen-Wichmann L, et al. (2012) Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter. Gene Therapy 19 1018-1029.
32. Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, et al. (2003) Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82: 269-279. (Pubitemid 36952300)
33. Williams S, Mustoe T, Mulcahy T, Griffiths M, Simpson D, et al. (2005) CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnology 5.
34. Campagnoli C, Fisk N, Overton T, Bennett P, Watts T, et al. (2000) Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 95 1967-1972. (Pubitemid 30151633)
35. Martin MA, Bhatia M (2005) Analysis of the Human Fetal Liver Hematopoietic Microenvironment. Stem cells and Development 14: 493-504. (Pubitemid 41780802)
36. Murdoch B, Gallacher L, Awaraji C, Hess DA, Keeney M, et al. (2001) Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. FASEB Journal 15: 1628-1630.
37. Golfier F, Barcena A, Cruz J, Harrison MR, Muench MO (1999) Mid-trimester fetal livers are a rich source of CD341/11 cells for transplantation. Bone Marrow Transplantation 24: 451-461. (Pubitemid 29423622)
38. Nava S, Westgren M, Jaksch M, Tibell A, Broomé U, et al. (2005) Characterization of cells in the developing human liver. Differentiation 73: 249-260. (Pubitemid 41602431)
39. Rollini P, Kaiser S, Faes-van't Hull E, Kapp U, Leyvraz S (2004) Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood 103: 1166-1170. (Pubitemid 38129587)
40. Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, et al. (2013) Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.121: 752-758. Blood 121: 752-758.
41. Luther-Wyrsch A, Costello E, Thali M, Beutti E, Nissen C, et al. (2001) Stable Transduction with Lentiviral Vectors and Amplification of Immature Hematopoietic Progenitors from Cord Blood of Preterm Human Fetuses. Hum Gene Ther 12: 377-389. (Pubitemid 32186650)
42. Holyoake TL, Nicolini FE, Eaves CJ (1999) Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27: 1418-1427. (Pubitemid 29409461)
43. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM (1996) The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 87: 3500-3507. (Pubitemid 26115384)
44. Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, et al. (2006) Promoter Dependence of Transgene Expression by Lentivirus-Transduced Human Blood-Derived Endothelial Progenitor Cells. Stem Cells 24: 199-208.
45. Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, et al. (2013) Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341.
46. Astrakhan A, Sather BD, Ryu BY, Khim S, Singh S, et al. (2012) Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome. Blood 119: 4395-4407.
47. van Til N, de Boer H, Mashamba N, Wabik A, Huston M, et al. (2012) Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene. Molecular Therapy 20: 1968-1980.